Literature DB >> 33728247

Expression of tyrosine pathway enzymes in mice demonstrates that homogentisate 1,2-dioxygenase deficiency in the liver is responsible for homogentisic acid-derived ochronotic pigmentation.

Peter J M Wilson1, Lakshminarayan R Ranganath1,2, George Bou-Gharios1, James A Gallagher1, Juliette H Hughes1.   

Abstract

Alkaptonuria (AKU) is caused by homogentisate 1,2-dioxygenase (HGD) deficiency. This study aimed to determine if HGD and other enzymes related to tyrosine metabolism are associated with the location of ochronotic pigment. Liver, kidney, skin, bone, brain, eyes, spleen, intestine, lung, heart, cartilage, and muscle were harvested from 6 AKU BALB/c Hgd -/- (3 females, 3 males) and 4 male C57BL/6 wild type (WT) mice. Hgd, 4-hydroxyphenylpyruvate dioxygenase (4-Hppd), tyrosine hydroxylase (Th), and tyrosinase (Tyr) mRNA expression was investigated using qPCR. Adrenal gland and gonads from AKU Hgd tm1a -/- mice were LacZ stained, followed by qPCR analysis of Hgd mRNA. The liver had the highest expression of Hgd, followed by the kidney, with none detected in cartilage or brain. Low-level Hgd expression was observed within developing male germ cells within the testis and epididymis in Hgd tm1a -/-. 4-Hppd was most abundant in liver, with smaller amounts in kidney and low-level expression in other tissues. Th was expressed mainly in brain and Tyr was found primarily in the eyes. The tissue distribution of both Hgd and 4-Hppd suggest that ochronotic pigment in AKU mice is a consequence of enzymes within the liver, and not from enzymatic activity within ochronotic tissues. Excessive accumulation of HGA as ochronotic pigment in joints and other connective tissues originates from the circulation and therefore the extracellular fluid. The tissue distribution of both Th and Tyr suggests that these enzymes are not involved in the formation of HGA-derived ochronotic pigment.
© 2020 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM.

Entities:  

Keywords:  4‐hydroxyphenylpyruvate dioxygenase; LacZ reporter; alkaptonuria; homogentisate 1,2‐dioxygenase; tyrosinase; tyrosine hydroxylase

Year:  2020        PMID: 33728247      PMCID: PMC7932868          DOI: 10.1002/jmd2.12184

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  38 in total

1.  Nature of the defect in alcaptonuria.

Authors:  V G ZANNONI; J E SEEGMILLER; B N LA DU
Journal:  Nature       Date:  1962-03-10       Impact factor: 49.962

2.  The nature of the defect in tyrosine metabolism in alcaptonuria.

Authors:  B N LA DU; V G ZANNONI; L LASTER; J E SEEGMILLER
Journal:  J Biol Chem       Date:  1958-01       Impact factor: 5.157

3.  Ochronotic arthropathy: disappearance of alkaptonuria after liver transplantation for hepatitis B-related cirrhosis.

Authors:  Arzu Celebi Kobak; Gonca Oder; Senol Kobak; Mehmet Argin; Vedat Inal
Journal:  J Clin Rheumatol       Date:  2005-12       Impact factor: 3.517

4.  Ultrastructural examination of tissue in a patient with alkaptonuric arthropathy reveals a distinct pattern of binding of ochronotic pigment.

Authors:  Adam M Taylor; Brenda Wlodarski; Ian A Prior; Peter J M Wilson; Jonathan C Jarvis; Lakshminarayan R Ranganath; James A Gallagher
Journal:  Rheumatology (Oxford)       Date:  2010-02-24       Impact factor: 7.580

5.  Regional differences in the sympathetic innervation of the guinea pig large intestine by neuropeptide Y- and tyrosine hydroxylase-immunoreactive nerves of divergent extrinsic origin.

Authors:  K N Browning; S M Cunningham; L Duncan; J Timmermans; G M Lees
Journal:  J Comp Neurol       Date:  1999-08-09       Impact factor: 3.215

6.  Identification of the mutation in the alkaptonuria mouse model. Mutations in brief no. 216. Online.

Authors:  K Manning; J M Fernández-Cañón; X Montagutelli; M Grompe
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

7.  A quantitative ultrastructural investigation of tyrosine hydroxylase-immunoreactive axons in the hairy skin of the guinea pig.

Authors:  S Roth; W Kummer
Journal:  Anat Embryol (Berl)       Date:  1994-08

8.  Tissue distribution, intracellular localization and proteolytic processing of rat 4-hydroxyphenylpyruvate dioxygenase.

Authors:  Søren Neve; Lene Aarenstrup; Ditte Tornehave; Henrik Rahbek-Nielsen; Thomas Juhl Corydon; Peter Roepstorff; Karsten Kristiansen
Journal:  Cell Biol Int       Date:  2003       Impact factor: 3.612

9.  Collagen atomic scale molecular disorder in ochronotic cartilage from an alkaptonuria patient, observed by solid state NMR.

Authors:  Wing Ying Chow; Adam M Taylor; David G Reid; James A Gallagher; Melinda J Duer
Journal:  J Inherit Metab Dis       Date:  2011-07-07       Impact factor: 4.982

10.  Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.

Authors:  Giulia Bernardini; Marcella Laschi; Michela Geminiani; Daniela Braconi; Elisa Vannuccini; Pietro Lupetti; Fabrizio Manetti; Lia Millucci; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2015-03-12       Impact factor: 4.982

View more
  2 in total

1.  Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria.

Authors:  Andrew S Davison; Brendan P Norman; Hazel Sutherland; Anna M Milan; James A Gallagher; Jonathan C Jarvis; Lakshminarayan R Ranganath
Journal:  Metabolites       Date:  2022-05-25

2.  Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria.

Authors:  L R Ranganath; A M Milan; A T Hughes; A S Davison; Khedr M; B P Norman; G Bou-Gharios; J A Gallagher; R Imrich; J B Arnoux; M Rudebeck; B Olsson
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.